Nuclein has developed the DASH™ Rapid PCR System, a point-of-care platform that delivers sample-to-answer PCR results for infectious diseases in just 15 minutes. This device provides high sensitivity and specificity, making it suitable for CLIA-waived environments and addressing the need for rapid and accurate diagnostic testing.
Funding
$43M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional PCR testing for infectious diseases often requires sending samples to a central lab, resulting in long turnaround times that delay diagnosis and treatment. Point-of-care testing options may lack the sensitivity and specificity of lab-based PCR, compromising accuracy.
Solution
The DASH™ Rapid PCR System is a compact, point-of-care platform that delivers rapid, sample-to-answer PCR results for infectious diseases in approximately 15 minutes. The system is designed for ease of use in CLIA-waived environments, providing central lab-quality results with high sensitivity and specificity. Its speed and simplicity enable faster clinical decision-making and improved patient outcomes.
Target Audience
The primary target audience includes healthcare providers in point-of-care settings, such as clinics and urgent care centers, who require rapid and accurate diagnostic testing for infectious diseases.
Features
- Sample-to-answer PCR testing in 15 minutes
- High sensitivity (Limit of Detection of 150 cp/mL)
- Designed for use in CLIA-waived settings
- Simple, intuitive operation (as easy to use as a coffee maker)
- Compatible with a wide range of sample types
- Small and robust design (4” wide)
- Multiplex-capable